DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
An All-in-One Photothermal Nanocomposite Hydrogel for Controlling Inducible Transgene Expression
We have developed a remotely near-infrared (NIR)-activated, implantable fibrin hydrogel for the controlled induction of transgene expression, designed to decouple the therapeutic efficacy of rapamycin from its systemic toxicity. Rapamycin, a drug widely used in clinical practice as an immunosuppressant and antiproliferative agent, is a potent transcriptional inducer that enables tightly regulated temporal transgene expression through chemically induced dimerization. However, its utility as a dimerizer is hindered by the unintended systemic immunosuppression and off-target effects inherent to its conventional administration. To address this, we developed poly(lactic-co-glycolic acid) (PLGA) nanoparticles to encapsulate rapamycin, aiming to facilitate localized delivery and enhance drug stability. Engineered cells harboring a dual heat- and dimerizer-responsive gene switch exhibited robust reporter transgene expression following nanoparticle treatment and thermal activation. Nanoencapsulation preserved rapamycin activity against thermal and hydrolytic degradation, enabling superior, long-term dimerizer function compared to the free drug. To create a remotely actuated platform, we developed photothermal hydrogels by incorporating hollow gold nanoparticles and rapamycin-loaded PLGA nanoparticles within a fibrin matrix hosting the reporter cells. In mice, NIR irradiation of subcutaneously implanted constructs achieved transgene induction levels comparable to systemic administration of rapamycin. Notably, nanoparticle-mediated delivery resulted in negligible circulating rapamycin concentrations. Furthermore, localized rapamycin release initially promoted a pro-healing M2 macrophage phenotype, followed by a late-stage transition toward an M1-dominant profile that likely facilitated the clearance of scaffold degradation products. In hydrogels incorporating cells harboring a gene switch to control human VEGF165 production, NIR irradiation triggered a robust angiogenic cascade characterized by transient erythema followed by an increase in CD31+ microvascular density. Collectively, these data demonstrate the potential of this light-triggered and rapamycin-dependent platform as a customizable and safe tool for achieving the control required to advance the next-generation of site-specific, transgenic protein therapies., This work was funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe”, grant numbers PID2021-126325OB-I00 (to N.V.), PID2023-146091OB-I00 (to M.A.), CEX2023-001286-S (to M.A.), by grants PI22/00939 and PI25/01326 from the Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union (to L.S.), and by the Autonomous Community of Madrid, Spain, grant P2022/BMD-7406 (to N.V.), Peer reviewed
Project:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-126325OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2023-146091OB-I00
,
ISCIII / Plan Estatal de Investigación Científica PI22-00939
,
ISCIII / Técnica y de Innovación 2021-2023 PI25-01326
View at: http://hdl.handle.net/10261/435127